Latest Post

August 14, 2020

How the FDA PFDD initiative is bringing the patients voice earlier into drug development

In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.
Victoria Morgan

Victoria Morgan

Global Director, Segment Marketing


Search the Blog





  • Previous Posts
    Introducing Integrated Solutions

    May 15, 2020

    Speed to Market with a Platform Approach

    Fran DeGrazio

    Fran DeGrazio

    Chief Scientific Officer, Scientific Affairs

    By Your Side for Innovation

    February 19, 2020

    West’s Commitment to Innovation Helps Customers Respond to Key Healthcare Market Trends

    CIndy Reiss-Clark

    Cindy Reiss-Clark

    Sr. VP, Commercial Markets & Commercial Solutions

    By Your Side for Innovation

    November 13, 2019

    By Your Side for Speed to Market

    Chris Ryan

    Chris Ryan

    VP & GM, Global Generics

    Ready Pack System

    March 12, 2019

    Molecule to Market – Simplify the Journey™ for New Drug Products

    Cathy Chhour

    Cathy Chhour

    Sr. Technical Account Specialist, TCS

    West logo with Diamond

    October 19, 2016

    Leaders Round Table Helps Support West's Market-Led Strategy

    Taylor Pendergast

    West's Global Communications Team